Rebecca A. Gillespie

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Kizzmekia S. Corbett, Darin K. Edwards, Sarah R. Leist et al. · Nature · 2020 · 1.6K citations · Full text

Vaccination, Prototype Pathogen Preparedness, Vaccine Development +6

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Kizzmekia S. Corbett, Barbara J. Flynn, Kathryn E. Foulds et al. · New England Journal of Medicine · 2020 · 1.1K citations · Full text

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

Michael Joyce, Adam K. Wheatley, Paul V. Thomas et al. · Cell · 2016 · 340 citations · Full text

Vaccination, Influenza A Viruses, Group 2 +9

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

Masaru Kanekiyo, Michael Joyce, Rebecca A. Gillespie et al. · Nature Immunology · 2019 · 313 citations

Vaccination, Mosaic Nanoparticle Display, Cross-protection +6

Quadrivalent influenza nanoparticle vaccines induce broad protection

Seyhan Boyoglu-Barnum, Daniel Ellis, Rebecca A. Gillespie et al. · Nature · 2021 · 304 citations · Full text

Vaccination, Nanomedicine, Cross-protection +9